Grove City College is partnering with Quest Diagnostics, one the nation’s largest and best-known medical laboratory companies, to screen and possibly test students for coronavirus before they return to campus for in-person instruction next month.
Detailed instructions for the return process will be distributed to students in the near future.
“Quest Diagnostics has a national presence and a proven track record of experience in the screening, testing and ability to deliver results promptly to students wherever they are located. This is a critical step we are taking to safeguard the health of our campus before classes begin on Aug. 24. It also affords the College the opportunity to establish a baseline for the overall health of our community and the ability to benchmark trends throughout the semester. The Quest Diagnostics partnership is an integral component of our return to campus plan. Coupled with additional on-campus testing measures and protocols that monitor and maintain the health and safety of our community, we’re doing all that we can to mitigate risk associated with the virus,” College President Paul J. McNulty ’80 said.
In response to COVID-19, Quest Diagnostics is expanding their services to offer medical screening and testing to institutions of higher learning as they prepare to bring students back to campus. Quest is a preferred partner of Allegheny Health Network (AHN.) Grove City College recently signed on to AHN’s Physician Consultant Program, which provides expert advice and best practices guidance to businesses and institutions in dealing with the coronavirus pandemic.
For more about the College’s response to coronavirus/COVID 19, visit www.gcc.edu/covid19.